Q1 Earnings Estimate for Certara Issued By Leerink Partnrs

Certara, Inc. (NASDAQ:CERT) – Equities research analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for shares of Certara in a report released on Wednesday, February 26th. Leerink Partnrs analyst M. Cherny expects that the company will post earnings of $0.05 per share for the quarter. The consensus estimate for Certara’s current full-year earnings is $0.28 per share. Leerink Partnrs also issued estimates for Certara’s Q2 2025 earnings at $0.07 EPS, Q3 2025 earnings at $0.07 EPS, Q4 2025 earnings at $0.07 EPS and FY2026 earnings at $0.33 EPS.

A number of other research analysts have also recently weighed in on the stock. TD Cowen initiated coverage on shares of Certara in a research note on Thursday, February 27th. They issued a “buy” rating and a $16.00 target price on the stock. Barclays upped their price objective on Certara from $12.00 to $13.00 and gave the company an “equal weight” rating in a research note on Friday, February 28th. Stephens reissued an “overweight” rating and issued a $17.00 target price on shares of Certara in a research report on Thursday, February 27th. William Blair reaffirmed a “market perform” rating on shares of Certara in a research report on Thursday, February 27th. Finally, Robert W. Baird cut their price target on Certara from $18.00 to $13.00 and set a “neutral” rating for the company in a research note on Tuesday, November 5th. Four analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, Certara presently has an average rating of “Moderate Buy” and a consensus price target of $15.83.

Certara Price Performance

CERT opened at $11.85 on Monday. Certara has a fifty-two week low of $9.41 and a fifty-two week high of $19.87. The firm has a 50-day moving average of $12.50 and a 200 day moving average of $11.63. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.86 and a current ratio of 2.86. The firm has a market cap of $1.91 billion, a P/E ratio of -59.25, a PEG ratio of 9.29 and a beta of 1.57.

Hedge Funds Weigh In On Certara

A number of large investors have recently made changes to their positions in the stock. Vanguard Group Inc. raised its stake in shares of Certara by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 12,437,089 shares of the company’s stock valued at $132,455,000 after purchasing an additional 38,068 shares during the period. Wasatch Advisors LP increased its position in shares of Certara by 22.4% during the third quarter. Wasatch Advisors LP now owns 9,015,941 shares of the company’s stock valued at $105,577,000 after buying an additional 1,651,076 shares during the period. ArrowMark Colorado Holdings LLC lifted its holdings in shares of Certara by 164.2% in the fourth quarter. ArrowMark Colorado Holdings LLC now owns 6,213,278 shares of the company’s stock worth $66,171,000 after buying an additional 3,861,674 shares in the last quarter. Geneva Capital Management LLC lifted its holdings in shares of Certara by 0.7% in the third quarter. Geneva Capital Management LLC now owns 5,510,209 shares of the company’s stock worth $64,525,000 after buying an additional 37,392 shares in the last quarter. Finally, Teacher Retirement System of Texas boosted its position in shares of Certara by 13.9% in the fourth quarter. Teacher Retirement System of Texas now owns 4,557,951 shares of the company’s stock valued at $48,542,000 after acquiring an additional 557,348 shares during the period. 73.96% of the stock is owned by institutional investors.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.